Kessler RC, McLaughlin KA, Green JG, Gruber MJ, Sampson NA, Zaslavsky AM, Aguilar-Gaxiola S, Alhamzawi AO, Alonso J, Angermeyer M, et al. Childhood adversities and adult psychopathology in the WHO world mental health surveys. Br J Psychiatry. 2010;197(5):378–85.
Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord. 2002;68(2–3):167–81.
Dong M, Zeng L-N, Lu L, Li X-H, Ungvari GS, Ng CH, Chow IHI, Zhang L, Zhou Y, Xiang Y-T. Prevalence of suicide attempt in individuals with major depressive disorder: a meta-analysis of observational surveys. Psychol Med. 2018;49(10):1691–704.
Cai H, Jin Y, Liu S, Zhang Q, Zhang L, Cheung T, Balbuena L, Xiang Y-T. Prevalence of suicidal ideation and planning in patients with major depressive disorder: A meta-analysis of observation studies. J Affect Disord. 2021;293:148–58.
Bertolote JM, Fleischmann A, De Leo D, Wasserman D. Psychiatric diagnoses and suicide: revisiting the evidence. Crisis. 2004;25(4):147–55.
Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry. 2011;68(10):1058–64.
Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, Yu Y, Kou C, Xu X, Lu J, et al. Prevalence of mental disorders in china: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–24.
Cuijpers P, Javed A, Bhui K. The WHO world mental health report: a call for action. Br J Psychiatry. 2023;222(6):227–9.
Klonsky ED, May AM, Saffer BY. Suicide, suicide Attempts, and suicidal ideation. Annu Rev Clin Psychol. 2016;12:307–30.
Klonsky ED, May AM, Glenn CR. The relationship between nonsuicidal self-injury and attempted suicide: converging evidence from four samples. J Abnorm Psychol. 2012;122(1):231–7.
Baldini V, Gnazzo M, Varallo G, Atti AR, De Ronchi D, Fiorillo A, Plazzi G. Inflammatory markers and suicidal behavior: A comprehensive review of emerging evidence. Ann Gen Psychiatry. 2025;24(1):36.
Mazza MG, Lucchi S, Tringali AGM, Rossetti A, Botti ER, Clerici M. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84(Pt A):229–36.
Ait Tayeb AEK, Poinsignon V, Chappell K, Bouligand J, Becquemont L, Verstuyft C. Major depressive disorder and oxidative stress: a review of peripheral and genetic biomarkers according to clinical characteristics and disease stages. Antioxid (Basel). 2023;12(4).
Forbes M, Mohebbi M, Woods RL, Lotfaliany M, Reynolds CF, O’Neil A, McNeil JJ, Berk M. Triglyceride-glucose index and its association with depressive symptoms in older adults: a longitudinal analysis. J Affect Disord. 2025;384:80–5.
Liu J, Zhu X, Liu Y, Jia F, Yuan H, Wang Q, Zhang X, Li Z, Du X, Zhang X. Association between triglyceride glucose index and suicide attempts in patients with first-episode drug-naïve major depressive disorder. Front Psychiatry. 2023;14:1231524.
Liu J, Wang Y, Mu W, Liu Y, Tong R, Lu Z, Yuan H, Jia F, Zhang X, Li Z, et al. Association between triglyceride glucose index (TyG) and psychotic symptoms in patients with first-episode drug-naïve major depressive disorder. Front Psychiatry. 2024;15:1342933.
Uher R, Payne JL, Pavlova B, Perlis RH. Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV. Depress Anxiety. 2014;31(6):459–71.
Sproston NR, Ashworth JJ. Role of C-Reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, Yale SH. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ. 2016;115(6):317–21.
Lonkar N, Latz E, McManus RM. Neuroinflammation and immunometabolism in neurodegenerative diseases. Curr Opin Neurol. 2025;38(2):163–71.
Zhang W, Sun H-S, Wang X, Dumont AS, Liu Q. Cellular senescence, DNA damage, and neuroinflammation in the aging brain. Trends Neurosci. 2024;47(6):461–74.
Tseng K-Y, Stratoulias V, Hu W-F, Wu J-S, Wang V, Chen Y-H, Seelbach A, Huttunen HJ, Kulesskaya N, Pang C-Y, et al. Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhage. Cell Death Dis. 2023;14(2):128.
Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care. 2002;5(5):551–9.
Fève B, Bastard J-P. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5(6):305–11.
Maciejczyk M, Żebrowska E, Chabowski A. Insulin resistance and oxidative stress in the brain: What’s New? Int J Mol Sci. 2019;20(4).
Su YA, Ye C, Xin Q, Si T. Major depressive disorder with suicidal ideation or behavior in Chinese population: A scoping review of current evidence on disease assessment, burden, treatment and risk factors. J Affect Disord. 2023;340:732–42.
Cuomo A, Nikolova VL, Yalin N, Arnone D, Fagiolini A, Young AH. Pharmacological treatment of mixed States. CNS Spectr. 2017;22(2):186–95.
Schloesser RJ, Martinowich K, Manji HK. Mood-stabilizing drugs: mechanisms of action. Trends Neurosci. 2012;35(1):36–46.
Chen P-H, Tsai S-Y, Chen P-Y, Pan C-H, Su S-S, Chen C-C, Kuo C-J. Mood stabilizers and risk of all-cause, natural, and suicide mortality in bipolar disorder: A nationwide cohort study. Acta Psychiatr Scand. 2023;147(3):234–47.
Malhi GS, Tanious M, Das P, Coulston CM, Berk M. Potential mechanisms of action of lithium in bipolar disorder. Current Understanding. CNS Drugs. 2013;27(2):135–53.
Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, Thase ME, Winokur A, Van Nueten L, Manji H, et al. Efficacy and safety of intranasal Esketamine adjunctive to oral antidepressant therapy in Treatment-Resistant depression: A randomized clinical trial. JAMA Psychiatry. 2018;75(2):139–48.